Responding to the coronavirus outbreak, a federal agency relaxes requirements on medical device manufacturers.
Amid the coronavirus, the federal government eases restrictions on prescribing controlled substances by telehealth.
Health care licensing regulators grapple with innovation, safety, and expertise when credentialing providers.
In the face of a massive viral outbreak, a federal regulator issues unprecedented guidance on validating COVID-19 testing.
The federal government responds to the coronavirus pandemic by amending its foreign quarantine rules.
In the United States, disease outbreaks challenge emergency preparedness.
FDA clarifies enforcement priorities for medical device clinical decision support software.
Health care sharing ministries seem similar to traditional health insurance, but they evade the scrutiny of federal and state regulators.
As states legalize marijuana, regulators must determine how to oversee its use.
Two proposed rules aim to improve the rate of organ donations in the United States.
Online announcement declares that new tobacco age restrictions are effective immediately.
FDA’s approval of an Ebola vaccine can serve as a framework for drug development during other epidemics.